{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T17:12:47Z","timestamp":1784740367538,"version":"3.55.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,1,22]],"date-time":"2024-01-22T00:00:00Z","timestamp":1705881600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,1,22]],"date-time":"2024-01-22T00:00:00Z","timestamp":1705881600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81970545"],"award-info":[{"award-number":["81970545"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82170609"],"award-info":[{"award-number":["82170609"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82170592"],"award-info":[{"award-number":["82170592"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81700554"],"award-info":[{"award-number":["81700554"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2020KH006"],"award-info":[{"award-number":["ZR2020KH006"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Ji\u2019nan Science and Technology Development Project","award":["2020190790"],"award-info":[{"award-number":["2020190790"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hepatol Int"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1007\/s12072-023-10625-7","type":"journal-article","created":{"date-parts":[[2024,1,22]],"date-time":"2024-01-22T03:02:41Z","timestamp":1705892561000},"page":"952-963","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["The impact of an increased Fibrosis-4 index and the severity of hepatic steatosis on mortality in individuals living with diabetes"],"prefix":"10.1007","volume":"18","author":[{"given":"Xiaoyan","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixuan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yee Hui","family":"Yeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiwen","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoming","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fajuan","family":"Rui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjing","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengxia","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolong","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junping","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0973-8645","authenticated-orcid":false,"given":"Jie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,22]]},"reference":[{"key":"10625_CR1","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12963-015-0065-x","volume":"13","author":"N Sudharsanan","year":"2015","unstructured":"Sudharsanan N, Ali MK, Mehta NK, et al. Population aging, macroeconomic changes, and global diabetes prevalence, 1990\u20132008. Popul Health Metr 2015;13:33","journal-title":"Popul Health Metr"},{"issue":"388","key":"10625_CR2","first-page":"1459","volume":"2016","author":"GBD 2015 Mortality and Causes of Death Collaborators","year":"2015","unstructured":"GBD 2015 Mortality and Causes of Death Collaborators. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980\u20132015: a systematic analysis for the Global Burden of Disease Study. Lancet 2015;2016(388):1459\u20131544","journal-title":"Lancet"},{"key":"10625_CR3","first-page":"1513","volume":"387","author":"NCD Risk Factor Collaboration (NCD-RisC)","year":"1980","unstructured":"NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in diabetes since: a pooled analysis of 751 population-based studies with 44 million participants. Lancet 1980;387:1513\u20131530","journal-title":"Lancet"},{"key":"10625_CR4","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1161\/CIRCULATIONAHA.106.685628","volume":"116","author":"EL Barr","year":"2007","unstructured":"Barr EL, Zimmet PZ, Welborn TA, et al. Risk of cardiovascular and all-cause mortality in individuals with diabetes mellitus, impaired fasting glucose, and impaired glucose tolerance: the Australian Diabetes, Obesity, and Lifestyle Study (AusDiab). Circulation 2007;116:151\u2013157","journal-title":"Circulation"},{"key":"10625_CR5","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.jhep.2019.06.021","volume":"71","author":"ZM Younossi","year":"2019","unstructured":"Younossi ZM, Golabi P, de Avila L, et al. The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: a systematic review and meta-analysis. J Hepatol 2019;71:793\u2013801","journal-title":"J Hepatol"},{"key":"10625_CR6","doi-asserted-by":"publisher","first-page":"399","DOI":"10.2337\/dc20-1997","volume":"44","author":"R Lomonaco","year":"2021","unstructured":"Lomonaco R, Godinez Leiva E, Bril F, et al. Advanced liver fibrosis is common in patients with type 2 Diabetes followed in the outpatient setting: the need for systematic screening. Diabetes Care 2021;44:399\u2013406","journal-title":"Diabetes Care"},{"key":"10625_CR7","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/S2468-1253(19)30039-1","volume":"4","author":"J Li","year":"2019","unstructured":"Li J, Zou B, Yeo YH, et al. Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999\u20132019: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol 2019;4:389\u2013398","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10625_CR8","doi-asserted-by":"publisher","first-page":"E526","DOI":"10.1503\/cmaj.092144","volume":"182","author":"L Porepa","year":"2010","unstructured":"Porepa L, Ray JG, Sanchez-Romeu P, et al. Newly diagnosed diabetes mellitus as a risk factor for serious liver disease. CMAJ 2010;182:E526\u2013E531","journal-title":"CMAJ"},{"key":"10625_CR9","doi-asserted-by":"publisher","first-page":"2887","DOI":"10.1016\/j.numecd.2021.06.020","volume":"31","author":"CB Giorda","year":"2021","unstructured":"Giorda CB, Picariello R, Tartaglino B, et al. Hepatic fibrosis of any origin in a large population of type 2 diabetes patients. Nutr Metab Cardiovasc Dis 2021;31:2887\u20132894","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10625_CR10","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.arcmed.2020.11.010","volume":"52","author":"E Makri","year":"2021","unstructured":"Makri E, Goulas A, Polyzos SA. Epidemiology, pathogenesis, diagnosis and emerging treatment of nonalcoholic fatty liver disease. Arch Med Res 2021;52:25\u201337","journal-title":"Arch Med Res"},{"key":"10625_CR11","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1002\/hep.29085","volume":"65","author":"PS Dulai","year":"2017","unstructured":"Dulai PS, Singh S, Patel J, et al. Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: systematic review and meta-analysis. Hepatology 2017;65:1557\u20131565","journal-title":"Hepatology"},{"key":"10625_CR12","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1053\/j.gastro.2020.01.043","volume":"158","author":"RS Taylor","year":"2020","unstructured":"Taylor RS, Taylor RJ, Bayliss S, et al. Association between fibrosis stage and outcomes of patients with nonalcoholic fatty liver disease: a systematic review and meta-analysis. Gastroenterology 2020;158:1611-1625.e12","journal-title":"Gastroenterology"},{"key":"10625_CR13","doi-asserted-by":"publisher","first-page":"S14","DOI":"10.2337\/dc20-S002","volume":"43","author":"American Diabetes Association","year":"2020","unstructured":"American Diabetes Association. 2. Classification and diagnosis of diabetes:\u00a0standards of medical care in diabetes-2020. Diabetes Care 2020;43:S14\u2013S31","journal-title":"Diabetes Care"},{"key":"10625_CR14","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","volume":"73","author":"M Eslam","year":"2020","unstructured":"Eslam M, Newsome PN, Sarin SK, et al. A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement. J Hepatol 2020;73:202\u2013209","journal-title":"J Hepatol"},{"key":"10625_CR15","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1016\/S0140-6736(05)67402-8","volume":"366","author":"KG Alberti","year":"2005","unstructured":"Alberti KG, Zimmet P, Shaw J, IDF Epidemiology Task Force Consensus Group. The metabolic syndrome\u2013a new worldwide definition. Lancet 2005;366:1059\u20131062","journal-title":"Lancet"},{"key":"10625_CR16","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1002\/hep.21669","volume":"46","author":"A Vallet-Pichard","year":"2007","unstructured":"Vallet-Pichard A, Mallet V, Nalpas B, et al. FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. Comparison with liver biopsy and fibrotest. Hepatology 2007;46:32\u201336","journal-title":"Hepatology"},{"key":"10625_CR17","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1016\/j.cgh.2009.05.033","volume":"7","author":"AG Shah","year":"2009","unstructured":"Shah AG, Lydecker A, Murray K, et al. Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol 2009;7:1104\u20131112","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10625_CR18","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1111\/apt.15830","volume":"52","author":"ZM Younossi","year":"2020","unstructured":"Younossi ZM, Corey KE, Alkhouri N, et al. Clinical assessment for high-risk patients with non-alcoholic fatty liver disease in primary care and diabetology practices. Aliment Pharmacol Ther 2020;52:513\u2013526","journal-title":"Aliment Pharmacol Ther"},{"key":"10625_CR19","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1038\/ajg.2016.453","volume":"112","author":"S McPherson","year":"2017","unstructured":"McPherson S, Hardy T, Dufour JF, et al. Age as a confounding factor for the accurate non-invasive diagnosis of advanced NAFLD fibrosis. Am J Gastroenterol 2017;112:740\u2013751","journal-title":"Am J Gastroenterol"},{"key":"10625_CR20","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1007\/s13340-020-00453-7","volume":"12","author":"N Kawata","year":"2020","unstructured":"Kawata N, Takahashi H, Iwane S, et al. FIB-4 index-based surveillance for advanced liver fibrosis in diabetes patients. Diabetol Int 2020;12:118\u2013125","journal-title":"Diabetol Int"},{"key":"10625_CR21","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1016\/j.jhep.2021.07.035","volume":"75","author":"D Kim","year":"2021","unstructured":"Kim D, Konyn P, Sandhu KK, et al. Metabolic dysfunction-associated fatty liver disease is associated with increased all-cause mortality in the United States. J Hepatol 2021;75:1284\u20131291","journal-title":"J Hepatol"},{"key":"10625_CR22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0269070","volume":"17","author":"J Park","year":"2022","unstructured":"Park J, Kwon HJ, Sohn W, et al. Risk of liver fibrosis in patients with prediabetes and diabetes mellitus. PLoS ONE 2022;17: e0269070","journal-title":"PLoS ONE"},{"key":"10625_CR23","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1002\/hep.27981","volume":"63","author":"EM Koehler","year":"2016","unstructured":"Koehler EM, Plompen EP, Schouten JN, et al. Presence of diabetes mellitus and steatosis is associated with liver stiffness in a general population: the Rotterdam study. Hepatology 2016;63:138\u2013147","journal-title":"Hepatology"},{"key":"10625_CR24","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1111\/apt.13405","volume":"43","author":"I Doycheva","year":"2016","unstructured":"Doycheva I, Cui J, Nguyen P, et al. Non-invasive screening of diabetics in primary care for NAFLD and advanced fibrosis by MRI and MRE. Aliment Pharmacol Ther 2016;43:83\u201395","journal-title":"Aliment Pharmacol Ther"},{"key":"10625_CR25","doi-asserted-by":"publisher","first-page":"2180","DOI":"10.1002\/hep.26072","volume":"57","author":"D van der Poorten","year":"2013","unstructured":"van der Poorten D, Samer CF, Ramezani-Moghadam M, et al. Hepatic fat loss in advanced nonalcoholic steatohepatitis: are alterations in serum adiponectin the cause? Hepatology 2013;57:2180\u20132188","journal-title":"Hepatology"},{"key":"10625_CR26","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1111\/apt.12658","volume":"39","author":"GL Wong","year":"2014","unstructured":"Wong GL, Chan HL, Yu Z, et al. Coincidental metabolic syndrome increases the risk of liver fibrosis progression in patients with chronic hepatitis B\u2013a prospective cohort study with paired transient elastography examinations. Aliment Pharmacol Ther 2014;39:883\u2013893","journal-title":"Aliment Pharmacol Ther"},{"key":"10625_CR27","first-page":"1891","volume":"18","author":"J Sun","year":"2019","unstructured":"Sun J, Li Y, Sun X, Fan L, et al. Association between abdominal obesity and liver steatosis and fibrosis among patients with chronic hepatitis B measured by Fibroscan. Exp Ther Med 2019;18:1891\u20131898","journal-title":"Exp Ther Med"},{"key":"10625_CR28","first-page":"244","volume":"9","author":"M Shaheen","year":"2020","unstructured":"Shaheen M, Schrode KM, Kermah D, et al. Prevalence and predictors of nonalcoholic steatohepatitis using multiple non-invasive methods: data from NHANES III. J Liver 2020;9:244","journal-title":"J Liver"},{"key":"10625_CR29","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1007\/s12072-020-10094-2","volume":"14","author":"M Eslam","year":"2020","unstructured":"Eslam M, Sarin SK, Wong VW, et al. The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease. Hepatol Int 2020;14:889\u2013919","journal-title":"Hepatol Int"}],"container-title":["Hepatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-023-10625-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12072-023-10625-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-023-10625-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T11:08:48Z","timestamp":1716548928000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12072-023-10625-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,22]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["10625"],"URL":"https:\/\/doi.org\/10.1007\/s12072-023-10625-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3341519\/v1","asserted-by":"object"}]},"ISSN":["1936-0533","1936-0541"],"issn-type":[{"value":"1936-0533","type":"print"},{"value":"1936-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,22]]},"assertion":[{"value":"10 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted following the guidelines of the Declaration of Helsinki, and the National Center for Health Statistics Research Ethics Review Board approved the NHANES protocol.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Xiaoyan Ma, Yixuan Zhu, Yee Hui Yeo, Zhiwen Fan, Xiaoming Xu, Fajuan Rui, Wenjing Ni, Qi Gu, Xin Tong, Shengxia Yin, Xiaolong Qi, Junping Shi, Chao Wu and Jie Li declare that they have no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}